A detailed history of Dividend Assets Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dividend Assets Capital, LLC holds 1,638 shares of ABBV stock, worth $294,840. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,638
Previous 2,103 22.11%
Holding current value
$294,840
Previous $360,000 10.28%
% of portfolio
0.06%
Previous 0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $76,185 - $92,688
-465 Reduced 22.11%
1,638 $323,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $17,580 - $20,031
110 Added 5.52%
2,103 $383,000
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $6,145 - $7,113
-46 Reduced 2.26%
1,993 $297,000
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $9,673 - $12,037
73 Added 3.71%
2,039 $275,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $27,662 - $33,174
-200 Reduced 9.23%
1,966 $318,000
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $19,192 - $22,011
143 Added 7.07%
2,166 $291,000
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $10,640 - $12,078
100 Added 5.2%
2,023 $218,000
Q2 2021

Jul 23, 2021

SELL
$105.21 - $117.21 $23,777 - $26,489
-226 Reduced 10.52%
1,923 $217,000
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $10,230 - $11,262
100 Added 4.88%
2,149 $233,000
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $150,113 - $202,669
-1,865 Reduced 47.65%
2,049 $220,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $18,900 - $22,182
-220 Reduced 5.32%
3,914 $343,000
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $57,595 - $77,071
785 Added 23.44%
4,134 $406,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $27,090 - $41,071
420 Added 14.34%
3,349 $255,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $8,439 - $10,559
117 Added 4.16%
2,929 $259,000
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $177,099 - $212,924
2,812 New
2,812 $213,000
Q2 2019

Jul 12, 2019

SELL
$65.7 - $83.98 $173,513 - $221,791
-2,641 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $203,726 - $239,776
2,641 New
2,641 $213,000
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $210,702 - $282,150
-2,290 Closed
0 $0
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $30,002 - $32,900
-335 Reduced 12.76%
2,290 $221,000
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $183,356 - $234,202
2,625
2,625 $233,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dividend Assets Capital, LLC Portfolio

Follow Dividend Assets Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dividend Assets Capital, LLC with notifications on news.